Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-year randomized double-blind bifeprunox versus placebo and quetiapine study in schizophrenia
2007-001097-90Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bifeprunox in schizophrenia, sponsored by Lundbeck. Started Mar 2008; status: terminated.
02
Drugs
bifeprunox
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-001097-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001097-90.